5th Annual Pharmaceutical Regulatory Affairs Asia 2012

Asia presents huge commercial opportunity to the global pharma market. However this potential can only be realized with successful regulatory approval.

Key Topics

• Multiple influences on regulatory approval for clinical trials and marketing authorization
• Strategies for lifecycle management including IP, regulatory and drug delivery approaches
• Threats facing intellectual property and products in emerging markets and strategies to protect your IP, products and data exclusivity
• Strategies to optimize communication with health authorities

Who should Attend

Attendees from Pharmaceutical / Generics / Biopharmaceuticals companies, Regulatory authorities (government) & Ministry of Health, Clinical Research Organizations / Consultancies and Medical Devices / Diagnostics Companies.